Marta T. Bognar
Expertise in
12
conditions

Dr. Marta T. Bognar

Rheumatology
Arthritis Center Of North Georgia
957 Baxter Street, 
Athens, GA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
12
conditions
Arthritis Center Of North Georgia
957 Baxter Street, 
Athens, GA 

Overview

Marta Bognar is a Rheumatologist practicing medicine in Athens, Georgia.

Dr. Bognar is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Osteoporosis, Postmenopausal Osteoporosis, and Psoriatic Arthritis.

Dr. Bognar is board certified in American Board Of Internal Medicine, Rheumatology - 1997. She is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 7 clinical trials. Dr. Bognar is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in GA

Board Certifications

American Board Of Internal Medicine, Rheumatology - 1997

Fellowships

Emory University, Rheumatology, 1997

Hospital Affiliations

Northeast Georgia Medical Center, Inc
St Mary's Hospital
Chatuge Regional Hospital
Piedmont Athens Regional Medical Center
Northeast Georgia Medical Center Habersham

Languages Spoken

English
Hungarian

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Arthritis Center of North Georgia
957 Baxter Street, Athens, GA 30606

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: June 24, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Completed
Publish Date: March 20, 2026
Intervention Type: Other, Biological
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
View 6 Less Clinical Trials

1 Total Publications

Multicentric reticulohistiocytosis post-COVID-19: a case report.
Multicentric reticulohistiocytosis post-COVID-19: a case report.
Journal: AME case reports
Published: August 28, 2023
Similar Doctors
Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required
Before you request

Arthritis Center Of North Georgia

957 Baxter Street, 
Athens, GA 
 (0.1 miles away)
706-410-9270
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Brent Flickinger is a Rheumatologist practicing medicine in Athens, Georgia. Dr. Flickinger is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Microscopic Polyangiitis, Scleredema, and Psoriatic Arthritis. Dr. Flickinger is board certified in American Board Of Internal Medicine, Rheumatology - 2007. Dr. Flickinger is currently accepting new patients.

Expertise in
13
conditions
Expertise in
13
conditions
Referral required
Before you request

Emory Clinic At 1365 Clifton Road

1365 Clifton Road Northeast, BldgA, 
Atlanta, GA 
 (54.7 miles away)
404-778-4366
Languages Spoken:
English, Farsi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Arezou Khosroshahi is a Rheumatologist practicing medicine in Atlanta, Georgia. Dr. Khosroshahi is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses IgG4-Related Disease, Lupus Nephritis, MAGIC Syndrome, and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. Dr. Khosroshahi is board certified in American Board Of Internal Medicine, 2010. Dr. Khosroshahi is currently accepting new patients.

Expertise in
44
conditions
Dr. Tracy L. Lovell
Rheumatology
Expertise in
44
conditions
Dr. Tracy L. Lovell
Rheumatology
Referral may be required
Before you request

Northeast Georgia Diagnostic Associates And Clinic, LLC

1240 Jesse Jewell Parkway Southeast, Suite 500, 
Gainesville, GA 
 (35.3 miles away)
770-536-9864
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Tracy Lovell is a Rheumatologist practicing medicine in Gainesville, Georgia. Dr. Lovell is highly rated in 44 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Temporal Arteritis, Giant Cell Arteritis (GCA), and Juvenile Temporal Arteritis. Dr. Lovell is board certified in American Board Of Internal Medicine, Rheumatology - 2006. Dr. Lovell is currently accepting new patients.

Frequently Asked Questions about Dr. Marta T. Bognar

How do I make an appointment with Dr. Marta T. Bognar?

You can book an appointment with Dr. Marta T. Bognar by calling their office at 706-410-9270. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Marta T. Bognar a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marta T. Bognar is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Marta T. Bognar specialize in?

While Dr. Marta T. Bognar is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Osteoporosis, and Postmenopausal Osteoporosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Marta T. Bognar participate in research or clinical trials?

Yes. Dr. Marta T. Bognar has published 1 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Marta T. Bognar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Marta T. Bognar accept my insurance?

Dr. Marta T. Bognar accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 706-410-9270 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bognar's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 29 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile